67230-47-1 Usage
Uses
Used in Peptide Synthesis:
BOC-PHE(3,5-DII,4-NH2)-OH is used as a starting material in peptide synthesis for the production of custom-designed peptides with specific sequences. The BOC protecting group is crucial for preventing unwanted chemical reactions during the synthesis process, ensuring the integrity and desired properties of the final peptide product.
Used in Pharmaceutical Research and Development:
In the pharmaceutical industry, BOC-PHE(3,5-DII,4-NH2)-OH is used as a building block for the development of therapeutic peptides. The additional functional groups on the phenyl ring can be tailored to create peptides with specific properties, making them suitable for various medical applications, such as drug delivery systems or targeted therapies.
Used in Biochemical Research:
BOC-PHE(3,5-DII,4-NH2)-OH is also utilized in biochemical research to study the structure and function of peptides. BOC-PHE(3,5-DII,4-NH2)-OH can be used to create peptides with unique properties, allowing researchers to investigate their interactions with other biomolecules and their potential roles in biological processes.
Overall, BOC-PHE(3,5-DII,4-NH2)-OH plays a significant role in the production of customized peptides for various research and therapeutic purposes, contributing to advancements in the fields of organic chemistry, pharmaceuticals, and biochemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 67230-47-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,2,3 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 67230-47:
(7*6)+(6*7)+(5*2)+(4*3)+(3*0)+(2*4)+(1*7)=121
121 % 10 = 1
So 67230-47-1 is a valid CAS Registry Number.
67230-47-1Relevant academic research and scientific papers
Escher et al.
, p. 860,862 (1978)
The synthesis and biological activities of analogues of the peptide hormone angiotensin II (AT) for use in photoaffinity labeling and receptor isolation are described. In the modified sequence of AT, Sar-Arg-Val-Tyr-Val-His-Pro-Phe, the aromatic residues
